Table I.
Ten Showcases of Protein Targets and Qualified Compounds that were Used for Evaluating the Performance of TAMOSIC in Comparison with MCM
| CHEMBL ID | Target name | Qualified compounds |
|---|---|---|
| CHEMBL220 | Acetylcholinesterase | 657 |
| CHEMBL221 | Cyclooxygenase-1 | 228 |
| CHEMBL230 | Cyclooxygenase-2 | 607 |
| CHEMBL243 | Human immunodeficiency virus type 1 protease | 2,180 |
| CHEMBL247 | Human immunodeficiency virus type 1 reverse transcriptase | 1,418 |
| CHEMBL203 | Epidermal growth factor receptor erbB1 | 704 |
| CHEMBL204 | Thrombin | 1,098 |
| CHEMBL2056 | Dopamine D1 receptor | 290 |
| CHEMBL260 | MAP kinase p38 alpha | 850 |
| CHEMBL235 | Peroxisome proliferator-activated receptor gamma | 991 |